Fast and Environmentally Friendly Microfluidic Technique for the Fabrication of Polymer Microspheres

Microfluidic Fabrication of Micropolymer Inclusion Beads for the Recovery of Gold from Electronic Scrap

A composite material, referred to as micropolymer inclusion beads (μPIBs), was fabricated for the first time using a microfluidic technique and applied successfully for the recovery of Au(III) from simulated digests of electronic scrap. Best results for the extraction of Au(III) were achieved with μPIBs consisting of 55% (m/m) poly(vinyl chloride) as the base polymer, 35% (m/m) Aliquat 336 as the extractant, and 10% (m/m) 1-tetradecanol as a modifier. The size and surface morphology of the μPIBs were examined using optical microscopy and scanning electron microscopy, respectively. A batch of 200 mg μPIBs allowed the complete and selective extraction of Au(III) (2.85 mg) from 50 mL of a simulated digest of electronic scrap containing other metal ions, including 1365 mg Cu(II). The extracted Au(III) was quantitatively stripped from the μPIBs into 50 mL of 0.1 mol L^-1 solution of thiourea. No Cu(II) and only sub-microgram levels of Cd(II) and Zn(II) were detected in this solution, thus confirming the suitability of the μPIBs for the efficient recovery of Au(III) from digests of electronic scrap. The microfluidic method used in this study is expected to be applicable for the fabrication of μPIBs for the selective separation of other chemical species by varying the composition of the beads.

Recent advances in the design of microfluidic technologies for the manufacture of drug releasing particles

Drug releasing particles are valued for their ability to deliver therapeutics to targeted locations and for their controllable release patterns. The development of microfluidic technologies, which are designed specifically to manipulate small amounts of fluids, to manufacture particles for drug delivery applications reflects a recent trend due to the advantages they confer in terms of control over particle size and material composition. This review takes a comprehensive look at the different types of microfluidic devices used to fabricate such particles from different types of biomaterials, and at how the on-chip features enable the production of particles with different types of properties. The review concludes by suggesting avenues for future work that will enable these technologies to fulfill their potential and be used in industrial settings for the manufacture of drug releasing particles with unique capabilities.

Detection of Metal-Doped Fluorescent PVC Microplastics in Freshwater Mussels

The large-scale production of plastic and the resulting release of waste is leading to a huge accumulation of micro-sized particles in the environment that could have an impact on not only aquatic organisms but also on humans. Despite the extensive literature on the subject, there is still an insufficient harmonization of methodologies for the collection and analysis of microplastics (MPs) in complex matrices; especially for high density polymers; such as polyvinyl chloride (PVC), which tend to sink and accumulate in sediments, becoming available to benthonic organisms. In this article, mussels have been chosen as model for microplastic accumulation due to their extensive filtering activity and their wide distribution in both fresh and salt water basins. To facilitate the identification and quantification of microplastics taken up by mussels, novel fluorescent and metal-doped PVC microplastics (PVC-Platinum octaethylporphyrin (PtOEP) MPs in the size range of 100 µm) have been synthesized and characterized. For the analysis of the mussels following exposure, an enzymatic protocol using amylase, lipase, papain, and SDS for organic material digestion and a sucrose-ZnCl₂ density gradient for the selective separation of ingested microplastics has been developed. The final identification of MPs was performed by fluorescence microscopy. This work can greatly benefit the scientific community by providing a means to study the behavior of PVC MPs, which represent an example of a very relevant yet poorly studied high density polymeric contaminant commonly found in complex environmental matrices.

Hierarchically porous composite microparticles from microfluidics for controllable drug delivery

Abdominal wall defect repair remains a major clinical need, and a particle-based controllable drug delivery system offers a solution to this problem. Here, we present a new type of hierarchically porous microparticles (HPMs) composed of poly(lactic-co-glycolic acid) (PLGA) and hollow mesoporous silica nanoparticles (HMSNs) for the delivery. The HPMs are generated by drying microfluidic emulsion templates of HMSNs-dispersed PLGA solution. The resultant HPMs have tailorable porous structures, that provide a three-hierarchy architecture for the controlled release of actives. The first hierarchy is formed for controlling the drug release via physical absorption as a result of the presence of the HMSNs in the HPMs. The second hierarchy channels with small pores scattered throughout the surface of the HPMs are formed during evaporation of the solvent. The third hierarchy with openings on the surface of the HPMs is formed as a result of the inner droplets leaking out of the double emulsion templates during the PLGA solidification. Thus, by manipulating the flow of solutions during the microfluidic emulsification, the porous structures of HPMs can be easily and precisely adjusted, and the loaded drugs are delivered at the required rate. These features of the HPMs make them ideal for repairing abdominal wall defects.